跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RIVAROXABAN BAYER 15 MG + 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
RIVAROXABAN BAYER 15 MG + 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
RIVAROXABAN BAYER 15 MG + 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Bayer Hispania S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 7, 2023
Approval ID
1582ba8f4bd8b97c
Company
Bayer Hispania S.L.
Type
Standard
Approval Details
Approval Id
1582ba8f4bd8b97c
Drug Cima Aemps Name
RIVAROXABAN BAYER 15 MG + 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
88711
Holder Company Name
Bayer Hispania S.L.
Marketing Company Name
Bayer Hispania S.L.
Authorization Date
2023-03-07
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
15 mg/20 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Bayer Hispania S.L.
Active Ingredients
RIVAROXABAN
20 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 7, 2023
Approval ID
1582ba8f4bd8b97c
Type
Standard
Back to CIMA-AEMPS Approvals